Zevra Therapeutics (ZVRA) Total Non-Current Liabilities (2014 - 2026)
Zevra Therapeutics' Total Non-Current Liabilities came in at $56.76 million for Q3 2026, down 44.2% from $101.73 million a year earlier and down 9.3% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics' Total Non-Current Liabilities was $111.76 million, up 10.0% from FY2024.
- Total Non-Current Liabilities has increased in each of the last three years, with a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
- Going back by year, Total Non-Current Liabilities was $101.6 million in FY2024 (+16.9%), $86.91 million in FY2023 (+189.8%), $29.99 million in FY2022 (-3.0%) and $30.92 million in FY2021 (-59.9%).
- The Q3 2026 figure represents the lowest quarterly Total Non-Current Liabilities since Q2 2023.
- Year-over-year, Total Non-Current Liabilities has declined for three consecutive quarters, with an average decline of 9.3% over the last eight quarters.
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q3 2022 (growth of 411.7%), and the weakest in Q4 2021 (a decline of 59.9%).
- Business Quant data shows ZVRA's Total Non-Current Liabilities at $62.6 million (Q2 2026), $57.25 million (Q1 2026) and $111.76 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 56.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 56.76 Mn |
| Jun 30, 2026 | 62.60 Mn |
| Mar 31, 2026 | 57.25 Mn |
| Dec 31, 2025 | 111.76 Mn |
| Sep 30, 2025 | 101.73 Mn |
| Jun 30, 2025 | 102.45 Mn |
| Mar 31, 2025 | 97.61 Mn |
| Dec 31, 2024 | 101.60 Mn |
| Sep 30, 2024 | 102.36 Mn |
| Jun 30, 2024 | 97.39 Mn |
| Mar 31, 2024 | 82.39 Mn |
| Dec 31, 2023 | 86.91 Mn |
| Sep 30, 2023 | 77.04 Mn |
| Jun 30, 2023 | 46.33 Mn |
| Mar 31, 2023 | 47.17 Mn |
| Dec 31, 2022 | 29.99 Mn |
| Sep 30, 2022 | 25.70 Mn |
| Jun 30, 2022 | 24.94 Mn |
| Mar 31, 2022 | 4.09 Mn |
| Dec 31, 2021 | 30.92 Mn |
API Access
Zevra Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();